White matter injury in the neonatal hypoxic‐ischemic brain and potential therapies targeting microglia
Autor: | Dawei Sun, Derong Cui, Rongjiao Shao, Yue Hu |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Excitotoxicity medicine.disease_cause Neuroprotection Cerebral palsy 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine medicine Animals Humans Remyelination Pathological Inflammation Microglia business.industry Infant Newborn Brain Hypothermia medicine.disease White Matter 030104 developmental biology medicine.anatomical_structure Brain Injuries Hypoxia-Ischemia Brain medicine.symptom business Neuroscience 030217 neurology & neurosurgery Oxidative stress |
Zdroj: | Journal of Neuroscience Research. 99:991-1008 |
ISSN: | 1097-4547 0360-4012 |
DOI: | 10.1002/jnr.24761 |
Popis: | Neonatal hypoxic-ischemic (H-I) injury, which mainly causes neuronal damage and white matter injury (WMI), is among the predominant causes of infant morbidity (cerebral palsy, cognitive and persistent motor disabilities) and mortality. Disruptions to the oxygen and blood supply in the perinatal brain affect the cerebral microenvironment and may affect microglial activation, excitotoxicity, and oxidative stress. Microglia are significantly associated with axonal damage and myelinating oligodendrocytes, which are major pathological components of WMI. However, the effects of H-I injury on microglial functions and underlying transformation mechanisms remain poorly understood. The historical perception that these cells are major risk factors for ischemic stroke has been questioned due to our improved understanding of the diversity of microglial phenotypes and their alterable functions, which exacerbate or attenuate injuries in different regions in response to environmental instability. Unfortunately, although therapeutic hypothermia is an efficient treatment, death and disability remain the prognosis for a large proportion of neonates with H-I injury. Hence, novel neuroprotective therapies to treat WMI following H-I injury are urgently needed. Here, we review microglial mechanisms that might occur in the developing brain due to neonatal H-I injury and discuss whether microglia function as a double-edged sword in WMI. Then, we emphasize microglial heterogeneity, notably at the single-cell level, and sex-specific effects on the etiology of neurological diseases. Finally, we discuss current knowledge of strategies aiming to improve microglia modulation and remyelination following neonatal H-I injury. Overall, microglia-targeted therapy might provide novel and valuable insights into the treatment of neonatal H-I insult. |
Databáze: | OpenAIRE |
Externí odkaz: |